/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

M. van Glabbeke

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

247

Papers

45.9K

Citations

71

h-index

159

i10-index

M. van Glabbeke is an academic researcher. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Lymphoma Diagnosis and Treatment & Gastrointestinal Tumor Research and Treatment. The author has an h-index of 71, co-authored 210 publications.

Research Topics

Sarcoma Diagnosis and Treatment Lymphoma Diagnosis and Treatment Gastrointestinal Tumor Research and Treatment Vascular Tumors and Angiosarcomas Gastric Cancer Management and Outcomes

Papers by this author

works

Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer

2004 · New England Journal of Medicine · 3,113 citations

https://doi.org/10.1056/nejmoa032641

Jacques Bernier C. Domenge Mahmut Özsahin Katarzyna Łukawska‐Matuszewska

Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

2005 · Head & Neck · 1,733 citations

https://doi.org/10.1002/hed.20279

Jacques Bernier Jay S. Cooper Thomas F. Pajak M. van Glabbeke

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

2004 · The Lancet · 1,659 citations

https://doi.org/10.1016/s0140-6736(04)17098-0

Jaap Verweij Paolo G. Casali John Zalcberg A. Lecesne

Initial and Late Resistance to Imatinib in Advanced Gastrointestinal Stromal Tumors Are Predicted by Different Prognostic Factors: A European Organisation for Research and Treatment of Cancer–Italian Sarcoma Group–Australasian Gastrointestinal Trials Group Study

2005 · Journal of Clinical Oncology · 279 citations

https://doi.org/10.1200/jco.2005.11.601

M. van Glabbeke Jaap Verweij Paolo G. Casali Axel Le Cesne

A Phase II Study of Gefitinib for Patients with Advanced HER-1 Expressing Synovial Sarcoma Refractory to Doxorubicin-Containing Regimens

2008 · The Oncologist · 54 citations

https://doi.org/10.1634/theoncologist.2008-0065

Isabelle Ray‐Coquard Axel Le Cesne Jeremy Whelan Patrick Schöffski

Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma

2011 · British Journal of Cancer · 34 citations

https://doi.org/10.1038/bjc.2011.136

Nicolas Penel M. van Glabbeke Simone Mathoulin‐Pélissier Ian Judson

Research topics

topics

Sarcoma Diagnosis and Treatment

Lymphoma Diagnosis and Treatment

Gastrointestinal Tumor Research and Treatment

Vascular Tumors and Angiosarcomas

Gastric Cancer Management and Outcomes

Chat about Author

Papers

Chat

Click to start Chat